Logo image of AYX

Alteryx Inc (AYX) Stock Fundamental Analysis

NYSE:AYX - New York Stock Exchange, Inc. - US02156B1035 - Common Stock - Currency: USD

48.26  +0.01 (+0.02%)

After market: 48.28 +0.02 (+0.04%)

Fundamental Rating

3

AYX gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 284 industry peers in the Software industry. Both the profitability and financial health of AYX have multiple concerns. AYX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AYX had positive earnings in the past year.
AYX had a positive operating cash flow in the past year.
AYX had negative earnings in 4 of the past 5 years.
AYX had a positive operating cash flow in 4 of the past 5 years.
AYX Yearly Net Income VS EBIT VS OCF VS FCFAYX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M -300M

1.2 Ratios

AYX has a Return On Assets (-9.36%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of -94.21%, AYX is doing worse than 74.10% of the companies in the same industry.
Industry RankSector Rank
ROA -9.36%
ROE -94.21%
ROIC N/A
ROA(3y)-13.68%
ROA(5y)-8.14%
ROE(3y)-107.39%
ROE(5y)-64.18%
ROIC(3y)N/A
ROIC(5y)N/A
AYX Yearly ROA, ROE, ROICAYX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

AYX has a better Gross Margin (86.44%) than 93.88% of its industry peers.
In the last couple of years the Gross Margin of AYX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AYX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 86.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y-1.01%
AYX Yearly Profit, Operating, Gross MarginsAYX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

2

2. Health

2.1 Basic Checks

AYX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AYX has been increased compared to 1 year ago.
The number of shares outstanding for AYX has been increased compared to 5 years ago.
The debt/assets ratio for AYX is higher compared to a year ago.
AYX Yearly Shares OutstandingAYX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
AYX Yearly Total Debt VS Total AssetsAYX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

2.2 Solvency

AYX has an Altman-Z score of 1.24. This is a bad value and indicates that AYX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AYX (1.24) is worse than 60.07% of its industry peers.
The Debt to FCF ratio of AYX is 47.62, which is on the high side as it means it would take AYX, 47.62 years of fcf income to pay off all of its debts.
AYX has a Debt to FCF ratio (47.62) which is comparable to the rest of the industry.
AYX has a Debt/Equity ratio of 4.42. This is a high value indicating a heavy dependency on external financing.
AYX has a worse Debt to Equity ratio (4.42) than 86.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.42
Debt/FCF 47.62
Altman-Z 1.24
ROIC/WACCN/A
WACC8.56%
AYX Yearly LT Debt VS Equity VS FCFAYX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.45 indicates that AYX should not have too much problems paying its short term obligations.
The Current ratio of AYX (1.45) is comparable to the rest of the industry.
AYX has a Quick Ratio of 1.45. This is a normal value and indicates that AYX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AYX (1.45) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
AYX Yearly Current Assets VS Current LiabilitesAYX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2142.86% over the past year.
Measured over the past years, AYX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.42% on average per year.
The Revenue has grown by 13.42% in the past year. This is quite good.
The Revenue has been growing by 30.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2142.86%
EPS 3Y15.42%
EPS 5YN/A
EPS Q2Q%102.38%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y25.11%
Revenue growth 5Y30.77%
Sales Q2Q%16.57%

3.2 Future

Based on estimates for the next years, AYX will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.64% on average per year.
The Revenue is expected to grow by 17.39% on average over the next years. This is quite good.
EPS Next Y-10.23%
EPS Next 2Y8.99%
EPS Next 3Y6.08%
EPS Next 5Y19.64%
Revenue Next Year12.19%
Revenue Next 2Y12.05%
Revenue Next 3Y19.72%
Revenue Next 5Y17.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
AYX Yearly Revenue VS EstimatesAYX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AYX Yearly EPS VS EstimatesAYX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.75, the valuation of AYX can be described as expensive.
76.62% of the companies in the same industry are more expensive than AYX, based on the Price/Earnings ratio.
AYX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 29.63.
Based on the Price/Forward Earnings ratio of 37.59, the valuation of AYX can be described as expensive.
Based on the Price/Forward Earnings ratio, AYX is valued a bit cheaper than the industry average as 65.11% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.68, AYX is valued quite expensively.
Industry RankSector Rank
PE 33.75
Fwd PE 37.59
AYX Price Earnings VS Forward Price EarningsAYX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as AYX.
Industry RankSector Rank
P/FCF 134.14
EV/EBITDA N/A
AYX Per share dataAYX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.99%
EPS Next 3Y6.08%

0

5. Dividend

5.1 Amount

AYX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Alteryx Inc

NYSE:AYX (3/18/2024, 8:04:00 PM)

After market: 48.28 +0.02 (+0.04%)

48.26

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-06 2024-02-06/amc
Earnings (Next)04-25 2024-04-25/amc
Inst Owners0.23%
Inst Owner Change-100%
Ins Owners2%
Ins Owner Change0%
Market Cap3.49B
Analysts67.37
Price Target51.6 (6.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)334.33%
Min EPS beat(2)44.89%
Max EPS beat(2)623.77%
EPS beat(4)4
Avg EPS beat(4)185.62%
Min EPS beat(4)28.76%
Max EPS beat(4)623.77%
EPS beat(8)8
Avg EPS beat(8)114.46%
EPS beat(12)12
Avg EPS beat(12)109.5%
EPS beat(16)15
Avg EPS beat(16)105.31%
Revenue beat(2)2
Avg Revenue beat(2)6.1%
Min Revenue beat(2)2.94%
Max Revenue beat(2)9.26%
Revenue beat(4)3
Avg Revenue beat(4)3.25%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)9.26%
Revenue beat(8)7
Avg Revenue beat(8)6.12%
Revenue beat(12)10
Avg Revenue beat(12)5.66%
Revenue beat(16)14
Avg Revenue beat(16)5.16%
PT rev (1m)0%
PT rev (3m)1.05%
EPS NQ rev (1m)4.91%
EPS NQ rev (3m)23.52%
EPS NY rev (1m)8.66%
EPS NY rev (3m)8.69%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0.65%
Revenue NY rev (3m)0.74%
Valuation
Industry RankSector Rank
PE 33.75
Fwd PE 37.59
P/S 3.6
P/FCF 134.14
P/OCF 120.27
P/B 18.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.43
EY2.96%
EPS(NY)1.28
Fwd EY2.66%
FCF(TTM)0.36
FCFY0.75%
OCF(TTM)0.4
OCFY0.83%
SpS13.42
BVpS2.63
TBVpS-3.54
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.36%
ROE -94.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 86.44%
FCFM 2.68%
ROA(3y)-13.68%
ROA(5y)-8.14%
ROE(3y)-107.39%
ROE(5y)-64.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y-1.01%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 4.42
Debt/FCF 47.62
Debt/EBITDA N/A
Cap/Depr 8.33%
Cap/Sales 0.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z 1.24
F-Score5
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)90.56%
Cap/Depr(5y)125.53%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2142.86%
EPS 3Y15.42%
EPS 5YN/A
EPS Q2Q%102.38%
EPS Next Y-10.23%
EPS Next 2Y8.99%
EPS Next 3Y6.08%
EPS Next 5Y19.64%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y25.11%
Revenue growth 5Y30.77%
Sales Q2Q%16.57%
Revenue Next Year12.19%
Revenue Next 2Y12.05%
Revenue Next 3Y19.72%
Revenue Next 5Y17.39%
EBIT growth 1Y40.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year65.71%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y120.24%
FCF growth 3Y-18.72%
FCF growth 5Y6.08%
OCF growth 1Y127.66%
OCF growth 3Y-27.08%
OCF growth 5Y2.14%